Medtronic: Cheap And Acquisitive
Medtronic has experienced a significant decline in its stock price, dropping approximately 25% since February. Despite facing sector challenges and a disappointing spin-off, the company is making strategic acquisitions to drive future growth. With a current valuation that appears attractive, Medtronic remains a buy for investors looking for potential in the healthcare sector.
- ▪Medtronic shares have declined about 25% since February due to sector headwinds.
- ▪The company has made recent acquisitions, including SPR Therapeutics and CathWorks, to focus on innovation.
- ▪Medtronic is currently trading at 13-14 times adjusted FY2026 earnings guidance with a dividend yield near 4%.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Stock Ideas","item":"https://seekingalpha.com/stock-ideas"},{"@type":"ListItem","position":3,"name":"Long Ideas","item":"https://seekingalpha.com/stock-ideas/long-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4910158-medtronic-cheap-and-acquisitive"},"author":{"@type":"Person","name":"The Value…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
